Biologics, Cancer, Clinical Trials, Drug Development, Drug Targets, Easily Confused, Genetics, Mechanism of Action, Monoclonal Antibodies, Small Molecule Drugs / September 14, 2017

The Multiple Myeloma Landscape

View Post

Biologics, Biotech Basics, Cancer, Clinical Trials, Drug Development, Drug Targets, Mechanism of Action, Small Molecule Drugs, The WEEKLY / September 7, 2017

Eye Of The Cytokine Storm

View Post

Biologics, Biotech Basics, Clinical Trials, Drug Development, Mechanism of Action, The WEEKLY / August 31, 2017

Vaccines: Schooling The Herd

View Post

Biologics, Business of Biotech, Cancer, Clinical Trials, Deoxyribonucleic Acid (DNA), Drug Development, Drug Targets, Genetics, Genomics, Mechanism of Action, Ribonucleic Acid (RNA) / August 10, 2017

The Science Of CRISPR/Cas9

View Post

Cocktail Fodder, Drug Approvals, Drug Targets, Mechanism of Action, Small Molecule Drugs / July 13, 2017

Stopping A Big Problem: Blood Clots

View Post

Biotech Basics, Cancer, Genetics, Mechanism of Action / June 29, 2017

Breast Cancer Subtypes

View Post

Cancer, Clinical Trials, Deoxyribonucleic Acid (DNA), Drug Development, Drug Targets, Genomics, Mechanism of Action, Small Molecule Drugs / June 1, 2017

Epigenome: Writing, Reading & Erasing

View Post

Biologics, Biotech Basics, Cancer, Clinical Trials, Drug Development, Drug Targets, Mechanism of Action, Monoclonal Antibodies, Orphan Disease, Orphan Drugs / May 25, 2017

Nanobodies: These Are Not Your Mother’s mAbs

View Post

Biologics, Clinical Trials, Deoxyribonucleic Acid (DNA), Drug Development, Drug Targets, Mechanism of Action, Ribonucleic Acid (RNA) / May 18, 2017

Viruses Blasting Cancer

View Post

Biologics, Clinical Trials, Drug Development, Drug Targets, Mechanism of Action, Term of the Week, The WEEKLY / May 11, 2017

Phage — More Than Just A Phase

View Post

Antisense, Biotech Basics, Clinical Trials, Deoxyribonucleic Acid (DNA), Drug Development, Drug Targets, Mechanism of Action, Orphan Disease, Orphan Drugs, Ribonucleic Acid (RNA), The WEEKLY / April 27, 2017

RNA Therapeutics March Onward

View Post

Biologics, Biotech Basics, Cancer, Cardiovascular Disease, Clinical Trials, Deoxyribonucleic Acid (DNA), Drug Development, Drug Targets, Mechanism of Action, Monoclonal Antibodies, Ribonucleic Acid (RNA), Small Molecule Drugs, The WEEKLY / April 20, 2017

Putting The NA in DNA

View Post

Biologics, Business of Biotech, Cancer, Clinical Trials, Deoxyribonucleic Acid (DNA), Drug Development, Drug Targets, Genomics, Mechanism of Action, Ribonucleic Acid (RNA), The WEEKLY / April 6, 2017

The Science Of CRISPR/CAS9

View Post

Cancer, Clinical Trials, Deoxyribonucleic Acid (DNA), Drug Approvals, Drug Development, Drug Targets, Easily Confused, FDA, Mechanism of Action, The WEEKLY / March 30, 2017

The PARP Race Is On

View Post

Cancer, Clinical Trials, Cocktail Fodder, Deoxyribonucleic Acid (DNA), Drug Development, Drug Targets, Mechanism of Action, Small Molecule Drugs, Term of the Week, The WEEKLY / March 23, 2017

The Intrigue Of HIF

View Post

Biologics, Biotech Basics, Cancer, Clinical Trials, Drug Development, Drug Targets, Mechanism of Action, Monoclonal Antibodies, Small Molecule Drugs, The WEEKLY / March 16, 2017

The Mechanics Of Melanoma

View Post